DATA SHEET - Medsafe
VIREAD Data Sheet (24 April 2019) 4 of 46 Renal impairment, including cases of acute renal failure and Fanconi syndrome (renal tubular injury with severe hypophosphataemia), has been reported in association with the use of
Download DATA SHEET - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Gastrointestinal drugs - WHO archives
archives.who.intthose related to NSAID use). Eradication of H. pylori reduces the relapse rate to about 4–8%. This is undoubtedly cost-effective compared to the alternatives of long-term maintenance therapy with low-dose H 2-receptor antagonists or repeated treatment of recurrent ulcers.
Nutritional Support in Intensive Care Unit (ICU) Patients ...
lllnutrition.com- BMI very low or very high - Higher age - Prolonged starvation - High level of organ support in the ICU - Severe physiological impairment The common denominator of all these conditions is …
METABOLIC DISEASES OF DAIRY CATTLE Introduction
neospark.comMETABOLIC DISEASES OF DAIRY CATTLE Introduction Dairy cattle require minerals in their diet for optimal productivity. These are derived from the feed and fodder.
Guidelines for the Management of Hypomagnesaemia …
nssg.oxford-haematology.org.ukDepartment of Clinical Haematology H.95 Page 2 of 5 November 2015 V.1.0. Guidelines for the management of hypomagnesaemia in Adult Clinical Haematology
DRUG NAME: Everolimus - bccancer.bc.ca
www.bccancer.bc.careported in 14% of patients, is a class effect of rapamycin derivatives. S evere and fatal cases have been reported. Symptoms include hypoxia, pleural effusion, cough or dyspnea.
AUSTRALIAN PRODUCT INFORMATION APO-ZOLEDRONIC …
www.medicines.org.aumL injection solution requires no further dilution. Patients should also be administered an oral calcium supplement of 500 mg and a multiple vitamin containing 400 IU of Vitamin D daily.
Management of IV Fluids and Electrolyte Balance
www.utas.edu.auObjectives Having completed this session you will be able to: • Explain the uses of IV therapy, the role of red and white blood cells, platelets, plasma, and the six major electrolytes in intracellular and
ADULT REFEEDING GUIDELINES - NHS Wales
www.wales.nhs.ukHYWEL DDA LOCAL HEALTH BOARD Database No: 209 Page 5 of 32 Version 1 Adult Refeeding Guidelines 1. INTRODUCTION There is an identified need for clinical guidance for initiating oral, enteral or parenteral feeding in